Will the Early Use of Biomarkers Prevent the Development of Heart Failure?
There are several factors known to increase the risk of developing heart failure, with both a normal (HFpEF) and decreased (HFrEF) left ventricular ejection fraction. Prominent amongst these risks include increasing age, atherosclerotic heart disease (with/without myocardial infarction), systemic hypertension, and diabetes. These conditions are considered Stage A in the spectrum of heart failure (1) and surveillance is recommended but the specific methods have not been well defined. When there is evidence of a cardiac structural abnormality, such left ventricular hypertrophy or a reduction in the LVEF (Stage B), then specific therapy is recommended to prevent symptoms and progression of heart failure.
Source: Journal of Cardiac Failure - Category: Cardiology Authors: Eugene E. Wolfel Source Type: research
More News: Cardiology | Diabetes | Endocrinology | Heart | Heart Attack | Heart Disease | Heart Failure | Hypertension